Report Detail

Other Global Parkinson's Disease Market Size, Status and Forecast 2019-2025

  • RnM3554907
  • |
  • 24 June, 2019
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Other

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
In 2018, the global Parkinson's Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Parkinson's Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson's Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia

Market segment by Type, the product can be split into
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors

Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Parkinson's Disease status, future forecast, growth opportunity, key market and key players.
To present the Parkinson's Disease development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson's Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Parkinson's Disease Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Carbidopa/Levodopa
      • 1.4.3 Dopamine Receptor Agonists
      • 1.4.4 MAO-Inhibitors
    • 1.5 Market by Application
      • 1.5.1 Global Parkinson's Disease Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Parkinson's Disease Market Size
    • 2.2 Parkinson's Disease Growth Trends by Regions
      • 2.2.1 Parkinson's Disease Market Size by Regions (2019-2025)
      • 2.2.2 Parkinson's Disease Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Parkinson's Disease Market Size by by Players
      • 3.1.1 Global Parkinson's Disease Revenue by by Players (2014-2019)
      • 3.1.2 Global Parkinson's Disease Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
    • 3.2 Parkinson's Disease Key Players Head office and Area Served
    • 3.3 Key Players Parkinson's Disease Product/Solution/Service
    • 3.4 Date of Enter into Parkinson's Disease Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Parkinson's Disease Market Size by Type (2014-2019)
    • 4.2 Global Parkinson's Disease Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Parkinson's Disease Market Size (2014-2019)
    • 5.2 Parkinson's Disease Key Players in North America
    • 5.3 North America Parkinson's Disease Market Size by Type
    • 5.4 North America Parkinson's Disease Market Size by Application

    6 Europe

    • 6.1 Europe Parkinson's Disease Market Size (2014-2019)
    • 6.2 Parkinson's Disease Key Players in Europe
    • 6.3 Europe Parkinson's Disease Market Size by Type
    • 6.4 Europe Parkinson's Disease Market Size by Application

    7 China

    • 7.1 China Parkinson's Disease Market Size (2014-2019)
    • 7.2 Parkinson's Disease Key Players in China
    • 7.3 China Parkinson's Disease Market Size by Type
    • 7.4 China Parkinson's Disease Market Size by Application

    8 Japan

    • 8.1 Japan Parkinson's Disease Market Size (2014-2019)
    • 8.2 Parkinson's Disease Key Players in Japan
    • 8.3 Japan Parkinson's Disease Market Size by Type
    • 8.4 Japan Parkinson's Disease Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Parkinson's Disease Market Size (2014-2019)
    • 9.2 Parkinson's Disease Key Players in Southeast Asia
    • 9.3 Southeast Asia Parkinson's Disease Market Size by Type
    • 9.4 Southeast Asia Parkinson's Disease Market Size by Application

    10 India

    • 10.1 India Parkinson's Disease Market Size (2014-2019)
    • 10.2 Parkinson's Disease Key Players in India
    • 10.3 India Parkinson's Disease Market Size by Type
    • 10.4 India Parkinson's Disease Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Parkinson's Disease Market Size (2014-2019)
    • 11.2 Parkinson's Disease Key Players in Central & South America
    • 11.3 Central & South America Parkinson's Disease Market Size by Type
    • 11.4 Central & South America Parkinson's Disease Market Size by Application

    12 International Players Profiles

    • 12.1 Teva
      • 12.1.1 Teva Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Parkinson's Disease Introduction
      • 12.1.4 Teva Revenue in Parkinson's Disease Business (2014-2019))
      • 12.1.5 Teva Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Parkinson's Disease Introduction
      • 12.2.4 Novartis Revenue in Parkinson's Disease Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 GSK
      • 12.3.1 GSK Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Parkinson's Disease Introduction
      • 12.3.4 GSK Revenue in Parkinson's Disease Business (2014-2019)
      • 12.3.5 GSK Recent Development
    • 12.4 AbbVie
      • 12.4.1 AbbVie Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Parkinson's Disease Introduction
      • 12.4.4 AbbVie Revenue in Parkinson's Disease Business (2014-2019)
      • 12.4.5 AbbVie Recent Development
    • 12.5 Merck
      • 12.5.1 Merck Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Parkinson's Disease Introduction
      • 12.5.4 Merck Revenue in Parkinson's Disease Business (2014-2019)
      • 12.5.5 Merck Recent Development
    • 12.6 Boehringer Ingelheim
      • 12.6.1 Boehringer Ingelheim Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Parkinson's Disease Introduction
      • 12.6.4 Boehringer Ingelheim Revenue in Parkinson's Disease Business (2014-2019)
      • 12.6.5 Boehringer Ingelheim Recent Development
    • 12.7 Amneal + Impax
      • 12.7.1 Amneal + Impax Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Parkinson's Disease Introduction
      • 12.7.4 Amneal + Impax Revenue in Parkinson's Disease Business (2014-2019)
      • 12.7.5 Amneal + Impax Recent Development
    • 12.8 Lundbeck
      • 12.8.1 Lundbeck Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Parkinson's Disease Introduction
      • 12.8.4 Lundbeck Revenue in Parkinson's Disease Business (2014-2019)
      • 12.8.5 Lundbeck Recent Development
    • 12.9 Sun Pharma
      • 12.9.1 Sun Pharma Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Parkinson's Disease Introduction
      • 12.9.4 Sun Pharma Revenue in Parkinson's Disease Business (2014-2019)
      • 12.9.5 Sun Pharma Recent Development
    • 12.10 Wockhardt
      • 12.10.1 Wockhardt Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Parkinson's Disease Introduction
      • 12.10.4 Wockhardt Revenue in Parkinson's Disease Business (2014-2019)
      • 12.10.5 Wockhardt Recent Development
    • 12.11 UCB
    • 12.12 Bausch Health
    • 12.13 Acadia

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Parkinson's Disease. Industry analysis & Market Report on Parkinson's Disease is a syndicated market report, published as Global Parkinson's Disease Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Parkinson's Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,088.80
      4,633.20
      6,177.60
      3,603.60
      5,405.40
      7,207.20
      590,031.00
      885,046.50
      1,180,062.00
      325,143.00
      487,714.50
      650,286.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report